Nurix Therapeutics NRIX
NASDAQ NRIX
$23.34 -0.37 (-1.56%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Accumulated Expenses (2019 - 2026)

Updated

Nurix Therapeutics' Accumulated Expenses was $43.27 million in fiscal Q2 2026 (quarter ended May 31, 2026), up 16.9% from $37.01 million a year earlier but down 27.8% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Nov 30, 2025), Accumulated Expenses at Nurix Therapeutics came in at $54.85 million, up 44.4% from FY2024.

  • Accumulated Expenses has now increased for six consecutive fiscal years, with a five-year compound annual growth rate of 45.8% (FY2020 to FY2025).
  • In earlier fiscal years, Accumulated Expenses was $37.99 million in FY2024 (+52.2%), $24.97 million in FY2023 (+11.3%), $22.43 million in FY2022 (+54.2%) and $14.55 million in FY2021 (+74.7%).
  • Quarterly Accumulated Expenses has moved between $11.42 million (fiscal Q1 2022) and $59.95 million (fiscal Q1 2026) over five years.
  • Compared with a year earlier, Accumulated Expenses has increased for 12 straight quarters, with growth averaging 43.7% over the last eight quarters.
  • The best year-over-year quarter for Accumulated Expenses over five years was fiscal Q2 2022 (growth of 157.0%); the worst was fiscal Q2 2023 (a decline of 8.3%).
  • Per Business Quant data, NRIX's Accumulated Expenses in the three fiscal quarters before Q2 2026 was $59.95 million (Q1 2026), $54.85 million (Q4 2025) and $43.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Nurix Therapeutics 2.46 Bn 452.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 43.27 Mn
Feb 28, 2026 59.95 Mn
Nov 30, 2025 54.85 Mn
Aug 31, 2025 43.96 Mn
May 31, 2025 37.01 Mn
Feb 28, 2025 44.36 Mn
Nov 30, 2024 37.99 Mn
Aug 31, 2024 27.83 Mn
May 31, 2024 23.26 Mn
Feb 29, 2024 28.32 Mn
Nov 30, 2023 24.97 Mn
Aug 31, 2023 21.91 Mn
May 31, 2023 18.09 Mn
Feb 28, 2023 15.39 Mn
Nov 30, 2022 22.43 Mn
Aug 31, 2022 19.61 Mn
May 31, 2022 19.73 Mn
Feb 28, 2022 11.42 Mn
Nov 30, 2021 14.55 Mn
Aug 31, 2021 11.57 Mn
API Access

Nurix Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NRIX&period=max&api_key=YOUR_API_KEY